| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.024 | 0.6 |